 | • レポートコード：GIR-107A14851 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、腫瘍ジェネリック注射薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。腫瘍ジェネリック注射薬の種類別市場規模（大型分子薬品、小型分子薬品）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・腫瘍ジェネリック注射薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Teva Pharmaceutical、Pfizer、AstraZeneca、Roche、Eli Lilly、GlaxoSmithKline、Novartis、Mylan、Natco Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：大型分子薬品、小型分子薬品 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・腫瘍ジェネリック注射薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・腫瘍ジェネリック注射薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・腫瘍ジェネリック注射薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・腫瘍ジェネリック注射薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・腫瘍ジェネリック注射薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oncology Generic Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oncology Generic Injectable Drugs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Oncology Generic Injectable Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oncology Generic Injectable Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Large Molecule Drugs
Small Molecule Drugs
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Oncology Generic Injectable Drugs market are listed below:
Teva Pharmaceutical
Pfizer
AstraZeneca
Roche
Eli Lilly
GlaxoSmithKline
Novartis
Mylan
Natco Pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Oncology Generic Injectable Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Oncology Generic Injectable Drugs, with price, sales, revenue and global market share of Oncology Generic Injectable Drugs in 2018 and 2019.
Chapter 3, the Oncology Generic Injectable Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology Generic Injectable Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Oncology Generic Injectable Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Oncology Generic Injectable Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Oncology Generic Injectable Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology Generic Injectable Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Large Molecule Drugs
1.2.3 Small Molecule Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology Generic Injectable Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Oncology Generic Injectable Drugs Market Size & Forecast
1.4.1 Global Oncology Generic Injectable Drugs Sales in Value (2016-2026))
1.4.2 Global Oncology Generic Injectable Drugs Sales in Volume (2016-2026)
1.4.3 Global Oncology Generic Injectable Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Oncology Generic Injectable Drugs Production Capacity Analysis
1.5.1 Global Oncology Generic Injectable Drugs Total Production Capacity (2016-2026)
1.5.2 Global Oncology Generic Injectable Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oncology Generic Injectable Drugs Market Drivers
1.6.2 Oncology Generic Injectable Drugs Market Restraints
1.6.3 Oncology Generic Injectable Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Teva Pharmaceutical
2.1.1 Teva Pharmaceutical Details
2.1.2 Teva Pharmaceutical Major Business
2.1.3 Teva Pharmaceutical Oncology Generic Injectable Drugs Product and Services
2.1.4 Teva Pharmaceutical Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Oncology Generic Injectable Drugs Product and Services
2.2.4 Pfizer Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Oncology Generic Injectable Drugs Product and Services
2.3.4 AstraZeneca Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Oncology Generic Injectable Drugs Product and Services
2.4.4 Roche Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Oncology Generic Injectable Drugs Product and Services
2.5.4 Eli Lilly Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Oncology Generic Injectable Drugs Product and Services
2.6.4 GlaxoSmithKline Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Oncology Generic Injectable Drugs Product and Services
2.7.4 Novartis Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Oncology Generic Injectable Drugs Product and Services
2.8.4 Mylan Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Natco Pharma
2.9.1 Natco Pharma Details
2.9.2 Natco Pharma Major Business
2.9.3 Natco Pharma Oncology Generic Injectable Drugs Product and Services
2.9.4 Natco Pharma Oncology Generic Injectable Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Oncology Generic Injectable Drugs Sales by Manufacturer
3.1 Global Oncology Generic Injectable Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oncology Generic Injectable Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oncology Generic Injectable Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Oncology Generic Injectable Drugs Manufacturer Market Share
3.4.2 Top 6 Oncology Generic Injectable Drugs Manufacturer Market Share
3.5 Global Oncology Generic Injectable Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oncology Generic Injectable Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oncology Generic Injectable Drugs Market Size by Region
4.1.1 Global Oncology Generic Injectable Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Oncology Generic Injectable Drugs Revenue by Region (2016-2026)
4.2 North America Oncology Generic Injectable Drugs Revenue (2016-2026)
4.3 Europe Oncology Generic Injectable Drugs Revenue (2016-2026)
4.4 Asia-Pacific Oncology Generic Injectable Drugs Revenue (2016-2026)
4.5 South America Oncology Generic Injectable Drugs Revenue (2016-2026)
4.6 Middle East and Africa Oncology Generic Injectable Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oncology Generic Injectable Drugs Sales in Volume by Type (2016-2026)
5.2 Global Oncology Generic Injectable Drugs Revenue by Type (2016-2026)
5.3 Global Oncology Generic Injectable Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oncology Generic Injectable Drugs Sales in Volume by Application (2016-2026)
6.2 Global Oncology Generic Injectable Drugs Revenue by Application (2016-2026)
6.3 Global Oncology Generic Injectable Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oncology Generic Injectable Drugs Sales by Type (2016-2026)
7.2 North America Oncology Generic Injectable Drugs Sales by Application (2016-2026)
7.3 North America Oncology Generic Injectable Drugs Market Size by Country
7.3.1 North America Oncology Generic Injectable Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Oncology Generic Injectable Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oncology Generic Injectable Drugs Sales by Type (2016-2026)
8.2 Europe Oncology Generic Injectable Drugs Sales by Application (2016-2026)
8.3 Europe Oncology Generic Injectable Drugs Market Size by Country
8.3.1 Europe Oncology Generic Injectable Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Oncology Generic Injectable Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oncology Generic Injectable Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Oncology Generic Injectable Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Oncology Generic Injectable Drugs Market Size by Region
9.3.1 Asia-Pacific Oncology Generic Injectable Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oncology Generic Injectable Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oncology Generic Injectable Drugs Sales by Type (2016-2026)
10.2 South America Oncology Generic Injectable Drugs Sales by Application (2016-2026)
10.3 South America Oncology Generic Injectable Drugs Market Size by Country
10.3.1 South America Oncology Generic Injectable Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Oncology Generic Injectable Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oncology Generic Injectable Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Oncology Generic Injectable Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Oncology Generic Injectable Drugs Market Size by Country
11.3.1 Middle East & Africa Oncology Generic Injectable Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oncology Generic Injectable Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oncology Generic Injectable Drugs Typical Distributors
12.3 Oncology Generic Injectable Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oncology Generic Injectable Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oncology Generic Injectable Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Teva Pharmaceutical Major Business
Table 5. Teva Pharmaceutical Oncology Generic Injectable Drugs Product and Services
Table 6. Teva Pharmaceutical Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Oncology Generic Injectable Drugs Product and Services
Table 10. Pfizer Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Oncology Generic Injectable Drugs Product and Services
Table 14. AstraZeneca Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Oncology Generic Injectable Drugs Product and Services
Table 18. Roche Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly Major Business
Table 21. Eli Lilly Oncology Generic Injectable Drugs Product and Services
Table 22. Eli Lilly Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Oncology Generic Injectable Drugs Product and Services
Table 26. GlaxoSmithKline Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Novartis Basic Information, Manufacturing Base and Competitors
Table 28. Novartis Major Business
Table 29. Novartis Oncology Generic Injectable Drugs Product and Services
Table 30. Novartis Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Oncology Generic Injectable Drugs Product and Services
Table 34. Mylan Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Natco Pharma Major Business
Table 37. Natco Pharma Oncology Generic Injectable Drugs Product and Services
Table 38. Natco Pharma Oncology Generic Injectable Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Oncology Generic Injectable Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Oncology Generic Injectable Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Oncology Generic Injectable Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Oncology Generic Injectable Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Oncology Generic Injectable Drugs Production Site of Key Manufacturer
Table 44. Oncology Generic Injectable Drugs New Entrant and Capacity Expansion Plans
Table 45. Oncology Generic Injectable Drugs Mergers & Acquisitions in the Past Five Years
Table 46. Global Oncology Generic Injectable Drugs Sales by Region (2016-2021e) & (K Units)
Table 47. Global Oncology Generic Injectable Drugs Sales by Region (2021-2026) & (K Units)
Table 48. Global Oncology Generic Injectable Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Oncology Generic Injectable Drugs Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Oncology Generic Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 51. Global Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Global Oncology Generic Injectable Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Oncology Generic Injectable Drugs Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Oncology Generic Injectable Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 55. Global Oncology Generic Injectable Drugs Price by Type (2021-2026) & (USD/Unit)
Table 56. Global Oncology Generic Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 57. Global Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 58. Global Oncology Generic Injectable Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Oncology Generic Injectable Drugs Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Oncology Generic Injectable Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 61. Global Oncology Generic Injectable Drugs Price by Application (2021-2026) & (USD/Unit)
Table 62. North America Oncology Generic Injectable Drugs Sales by Country (2016-2021e) & (K Units)
Table 63. North America Oncology Generic Injectable Drugs Sales by Country (2021-2026) & (K Units)
Table 64. North America Oncology Generic Injectable Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Oncology Generic Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Oncology Generic Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 67. North America Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 68. North America Oncology Generic Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 69. North America Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 70. Europe Oncology Generic Injectable Drugs Sales by Country (2016-2021e) & (K Units)
Table 71. Europe Oncology Generic Injectable Drugs Sales by Country (2021-2026) & (K Units)
Table 72. Europe Oncology Generic Injectable Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Oncology Generic Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Oncology Generic Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 75. Europe Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 76. Europe Oncology Generic Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 77. Europe Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 78. Asia-Pacific Oncology Generic Injectable Drugs Sales by Region (2016-2021e) & (K Units)
Table 79. Asia-Pacific Oncology Generic Injectable Drugs Sales by Region (2021-2026) & (K Units)
Table 80. Asia-Pacific Oncology Generic Injectable Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Oncology Generic Injectable Drugs Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Oncology Generic Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 83. Asia-Pacific Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 84. Asia-Pacific Oncology Generic Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 85. Asia-Pacific Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 86. South America Oncology Generic Injectable Drugs Sales by Country (2016-2021e) & (K Units)
Table 87. South America Oncology Generic Injectable Drugs Sales by Country (2021-2026) & (K Units)
Table 88. South America Oncology Generic Injectable Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Oncology Generic Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Oncology Generic Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 91. South America Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 92. South America Oncology Generic Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 93. South America Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 94. Middle East & Africa Oncology Generic Injectable Drugs Sales by Country (2016-2021e) & (K Units)
Table 95. Middle East & Africa Oncology Generic Injectable Drugs Sales by Country (2021-2026) & (K Units)
Table 96. Middle East & Africa Oncology Generic Injectable Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Oncology Generic Injectable Drugs Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Oncology Generic Injectable Drugs Sales by Type (2016-2021e) & (K Units)
Table 99. Middle East & Africa Oncology Generic Injectable Drugs Sales by Type (2021-2026) & (K Units)
Table 100. Middle East & Africa Oncology Generic Injectable Drugs Sales by Application (2016-2021e) & (K Units)
Table 101. Middle East & Africa Oncology Generic Injectable Drugs Sales by Application (2021-2026) & (K Units)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Oncology Generic Injectable Drugs Typical Distributors
Table 105. Oncology Generic Injectable Drugs Typical Customers
List of Figures
Figure 1. Oncology Generic Injectable Drugs Picture
Figure 2. Global Oncology Generic Injectable Drugs Sales Market Share by Type in 2020
Figure 3. Large Molecule Drugs
Figure 4. Small Molecule Drugs
Figure 5. Global Oncology Generic Injectable Drugs Sales Market Share by Application in 2020
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Oncology Generic Injectable Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Oncology Generic Injectable Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Oncology Generic Injectable Drugs Sales (2016-2026) & (K Units)
Figure 12. Global Oncology Generic Injectable Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Oncology Generic Injectable Drugs Production Capacity (2016-2026) & (K Units)
Figure 14. Global Oncology Generic Injectable Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Oncology Generic Injectable Drugs Market Drivers
Figure 16. Oncology Generic Injectable Drugs Market Restraints
Figure 17. Oncology Generic Injectable Drugs Market Trends
Figure 18. Global Oncology Generic Injectable Drugs Sales Market Share by Manufacturer in 2020
Figure 19. Global Oncology Generic Injectable Drugs Revenue Market Share by Manufacturer in 2020
Figure 20. Oncology Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Oncology Generic Injectable Drugs Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Oncology Generic Injectable Drugs Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Oncology Generic Injectable Drugs Sales Market Share by Region (2016-2026)
Figure 24. Global Oncology Generic Injectable Drugs Revenue Market Share by Region (2016-2026)
Figure 25. North America Oncology Generic Injectable Drugs Revenue (2016-2026) & (USD Million)
Figure 26. Europe Oncology Generic Injectable Drugs Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Oncology Generic Injectable Drugs Revenue (2016-2026) & (USD Million)
Figure 28. South America Oncology Generic Injectable Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Oncology Generic Injectable Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Global Oncology Generic Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 31. Global Oncology Generic Injectable Drugs Revenue Market Share by Type (2016-2026)
Figure 32. Global Oncology Generic Injectable Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Oncology Generic Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 34. Global Oncology Generic Injectable Drugs Revenue Market Share by Application (2016-2026)
Figure 35. Global Oncology Generic Injectable Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Oncology Generic Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 37. North America Oncology Generic Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 38. North America Oncology Generic Injectable Drugs Sales Market Share by Country (2016-2026)
Figure 39. North America Oncology Generic Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 40. United States Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Oncology Generic Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 44. Europe Oncology Generic Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 45. Europe Oncology Generic Injectable Drugs Sales Market Share by Country (2016-2026)
Figure 46. Europe Oncology Generic Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 47. Germany Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Oncology Generic Injectable Drugs Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Oncology Generic Injectable Drugs Revenue Market Share by Region (2016-2026)
Figure 56. China Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Oncology Generic Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 63. South America Oncology Generic Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 64. South America Oncology Generic Injectable Drugs Sales Market Share by Country (2016-2026)
Figure 65. South America Oncology Generic Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Oncology Generic Injectable Drugs Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Oncology Generic Injectable Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Oncology Generic Injectable Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Oncology Generic Injectable Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Oncology Generic Injectable Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の腫瘍ジェネリック注射薬市場予測（～2024年） Generic drugs are essential in oncology because some anticancer drugs are only available as generics. Scope of the Report: The worldwide market for Oncology Generic Injectable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx mill…- 世界の腫瘍用小分子薬剤市場 2021：企業別、地域別、種類・用途別 The Oncology Small Molecule Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の腫瘍学小分子薬市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Oncology Small Molecule Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in Ch…
- 世界の注射可能駆虫薬市場 2021：企業別、地域別、種類・用途別 The Injectable Anthelmintic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の凍結乾燥注射薬市場予測（～2024年） Scope of the Report: Based on type of packaging, the single-use vials segment is anticipated held major market share in 2018 and the trend is projected to continue during the forecast period. The global Lyophilized Injectable Drugs market is valued at xx million USD in 2018 and is expected to reach …